Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2291]
News [4645]
Articles [192]
Editorials [8]
Conferences [136]
elearning [9]
Sotorasib for advanced non-small cell lung cancer
Prof Fabrice Barlesi - Gustave Roussy, Villejuif, France
Sotorasib for advanced non-small cell lung cancer ( Prof Fabrice Barlesi - Gustave Roussy, Villejuif, France )
6 Nov 2020
VHL/HIF and VEGF inhibitors in clear cell renal cell carcinoma
Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA
VHL/HIF and VEGF inhibitors in clear cell renal cell carcinoma ( Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA )
4 Nov 2020
Bevacizumab-induced hypertension and proteinuria: A genome-wide analysis of...
Prof Federico Innocenti - University of North Carolina, Chapel Hill, USA
Bevacizumab-induced hypertension and proteinuria: A genome-wide analysis of more than 1,000 patients ( Prof Federico Innocenti - University of North Carolina, Chapel Hill, USA )
4 Nov 2020
The ENA virtual meeting 2020
Dr. Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA
The ENA virtual meeting 2020 ( Dr. Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA )
4 Nov 2020
Adagrasib in advanced/metastatic NSCLC with KRAS G12C mutation
Dr Pasi Janne - Dana Farber Cancer Institute, Boston, USA
Adagrasib in advanced/metastatic NSCLC with KRAS G12C mutation ( Dr Pasi Janne - Dana Farber Cancer Institute, Boston, USA )
4 Nov 2020
Development of novel inhibitors of KRASG12C
Dr Kevan Shokat - University of California San Francisco, San Francisco, USA
Development of novel inhibitors of KRASG12C ( Dr Kevan Shokat - University of California San Francisco, San Francisco, USA )
4 Nov 2020
Impact of angiotensin II pathway inhibition on tumour response to anti PD(L)1...
Dr Julius Strauss - National Institutes of Health, Bethseda, USA
Impact of angiotensin II pathway inhibition on tumour response to anti PD(L)1 based therapy ( Dr Julius Strauss - National Institutes of Health, Bethseda, USA )
4 Nov 2020
Critical issues in drug and biomarker development
Prof Tracy Lively - National Cancer Institute, USA
Critical issues in drug and biomarker development ( Prof Tracy Lively - National Cancer Institute, USA )
2 Nov 2020
Updates in radiation oncology from SIOG 2020
Dr Lucinda Morris - Sutherland Hospital, Sydney, Australia
Updates in radiation oncology from SIOG 2020 ( Dr Lucinda Morris - Sutherland Hospital, Sydney, Australia )
30 Oct 2020
Pragmatic geriatric assessment for cancer patients in Brazil
Dr Antonio Fabiano Ferreira Filho - Oncosinos, Novo Hamburgo, Brazil
Pragmatic geriatric assessment for cancer patients in Brazil ( Dr Antonio Fabiano Ferreira Filho - Oncosinos, Novo Hamburgo, Brazil )
30 Oct 2020
Treating elderly cancer patients during the COVID-19 pandemic
Dr Anna Mislang - Flinders Private Hospital, Bedford Park, Australia
Treating elderly cancer patients during the COVID-19 pandemic ( Dr Anna Mislang - Flinders Private Hospital, Bedford Park, Australia )
30 Oct 2020
Biomarker-driven clinical trials: promises and pitfalls
Dr Renzo Canetta - Independent consultant
Biomarker-driven clinical trials: promises and pitfalls ( Dr Renzo Canetta - Independent consultant )
29 Oct 2020

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation